U.S. Government Selects Biothera Compounds For National Radiation Countermeasure Evaluation

Published: Sep 18, 2006

EAGAN, Minn., Sept. 18 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has selected two Biothera drug candidates for research in a new program designed to identify and facilitate the development of radiation and nuclear medical countermeasures.

Back to news